Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Preventing Chronic Disease|March 11, 2021
Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease MappingDavid Zahrieh, Michael A Golafshar, Samir H Patel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling EffectsTodd A DeWees, Gina L Mazza, Michael A Golafshar, et al.
Seminars in Radiation Oncology|September 2, 2019
Analytical Methods for Observational Data to Generate Hypotheses and Inform Clinical DecisionsTodd A DeWees, Carlos E Vargas, Michael A Golafshar, et al.
Practical Radiation Oncology|November 25, 2015
It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survivalMichael C Roach, Sana Rehman, Todd A DeWees, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2016
Medically inoperable endometrial cancer in patients with a high body mass index (BMI): Patterns of failure after 3-D image-based high dose rate (HDR) brachytherapySahaja Acharya, Jacqueline Esthappan, Shahed Badiyan, et al.
Journal of Applied Clinical Medical Physics|March 29, 2021
A method for quantitative evaluations of scanning-proton dose distributionsBryce C Allred, Jie Shan, Daniel G Robertson, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2018
In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic TumorsLauren E Henke, Rojano Kashani, Jessica Hilliard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2018
Stereotactic Body Radiation Therapy for Central Early-Stage NSCLC: Results of a Prospective Phase I/II TrialMichael C Roach, Cliff G Robinson, Todd A DeWees, et al.
Pageof 8